Immunogenicity of the Two mRNA SARS-CoV-2 Vaccines in a Large Cohort of Dialysis Patients

Chronic kidney disease patients, especially those on hemodialysis, are at the highest risk of a severe course and death from COVID-19. Moreover, they appear to have suboptimal response in both cellular and humoral immunity after vaccination. The present study investigated humoral and cellular respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsoutsoura, Paraskevi, Xagas, Efstathios, Kolovou, Kyriaki, Gourzi, Polyxeni, Roussos, Sotirios, Hatzakis, Angelos, Boletis, Ioannis N., Marinaki, Smaragdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778780/
https://www.ncbi.nlm.nih.gov/pubmed/36547239
http://dx.doi.org/10.3390/idr14060093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778780/
https://www.ncbi.nlm.nih.gov/pubmed/36547239
http://dx.doi.org/10.3390/idr14060093

Ejemplares similares